In summary, our results revealed that HBMSCs-derived exosomes might attenuate the progression of PCa through exosomal miR-99b-5p mediated suppression of IGF1R, suggesting that HBMSCs-derived exosomes might be a potential therapeutic strategy for PCa. This evidence concerns the gene IGF1R and posterior cortical atrophy.